20260831-招银国际-比亚迪-002594.SZ-2Q26_earnings_signal_enhanced_cost_discipline_5页_1mb
报告摘要
BYD (1211 HK/002594 CH) Summary
Core Content
This report provides an analysis of BYD's financial performance and outlook for the next few years. It highlights the company's earnings, cost control measures, and future growth expectations. The report also includes financial metrics, valuation ratios, and key risks associated with investing in BYD.
Main Points
-
2Q26 Earnings Performance:
- Revenue fell by 3.2% YoY to RMB195bn, slightly below the forecast.
- Gross profit margin (GPM) improved to 18.9%, the highest since 2Q25, beating the forecast by 0.5ppts.
- Net profit increased by 30% YoY to RMB8.2bn, but still missed the forecast by 15% due to higher impairment losses.
-
Cost Control:
- Tightened cost control is evident in the stabilization of R&D spend and slower depreciation and amortization (D&A) growth.
- R&D investment in 1H26 declined 6.5% YoY, with a higher capitalization ratio (from 4% to 19%).
- D&A growth in 1H26 was only 5% YoY, the slowest since 1H20.
-
Outlook for 2H26 and FY27:
- Maintained FY26E sales volume forecast at 4.5mn units, with overseas contributing 40%.
- Revised FY26E revenue forecast down by 1% due to ASP miss, but raised GPM by 0.2ppts and cut R&D expenses by 9%.
- Raised FY26E net profit forecast by 3% to RMB36.1bn.
- Projected FY27E sales volume to rise 11% YoY to 5.0mn units.
- Expected stringent cost cuts to continue, leading to a 5% revision up in FY27E net profit to RMB44.1bn.
-
Valuation:
- Maintained a BUY rating and H-share target price of HK$125.00, based on a 22x revised FY27E P/E.
- A-share target price is based on the current A/H premium of 18%.
-
Key Risks:
- Lower sales volume or margins than expected.
- Sector de-rating.
Key Financial Metrics
| Metric | FY24A | FY25A | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|
| Revenue (RMB mn) | 777,102 | 803,965 | 825,103 | 902,415 | 966,157 |
| YoY growth (%) | 29.0 | 3.5 | 2.6 | 9.4 | 7.1 |
| Net profit (RMB mn) | 40,254.3 | 32,619.0 | 36,112.1 | 44,079.7 | 52,606.5 |
| YoY growth (%) | 34.0 | (19.0) | 10.7 | 22.1 | 19.3 |
| EPS (Reported) (RMB) | 13.85 | 3.61 | 3.96 | 4.83 | 5.77 |
| P/S (x) | 0.9 | 0.9 | 0.9 | 0.8 | 0.7 |
| P/E (x) | 5.7 | 21.8 | 19.9 | 16.3 | 13.7 |
| Yield (%) | 5.3 | 0.5 | 1.0 | 1.2 | 1.5 |
| ROE (%) | 24.8 | 15.1 | 13.7 | 14.8 | 15.6 |
| Net gearing (%) | (50.7) | (1.1) | (8.7) | (13.7) | (31.4) |
Financial Highlights (1H26)
- Sales Volume: Increased by 58.2% to 1,108,048 units.
- Revenue: Rose 29.5% to RMB194,590bn.
- Gross Profit: Increased by 30.0% to RMB36,737bn.
- R&D Expenses: Stabilized at RMB11,964bn.
- SG&A Expenses: Increased by 9.8% to RMB11,979bn.
- Net Profit: Increased by 101.8% to RMB8,241bn.
- Gross Margin: Rose 0.1ppts to 18.9%.
- Operating Margin: Increased 2.0ppts to 5.2%.
- Net Margin: Increased 1.5ppts to 4.2%.
Earnings Revisions (FY26E to FY28E)
| Metric | CMBIGM | Consensus | Diff. |
|---|---|---|---|
| Revenue (RMB mn) | 825,103 | 910,470 | -9.4% |
| Gross profit (RMB mn) | 150,288 | 169,102 | -11.1% |
| Operating profit (RMB mn) | 43,663 | 45,620 | -4.3% |
| Net profit (RMB mn) | 36,112 | 39,388 | -8.3% |
| Gross margin (%) | 18.2% | 18.6% | -0.4 ppts |
| Operating margin (%) | 5.3% | 5.0% | +0.3 ppts |
| Net margin (%) | 4.4% | 4.3% | +0.1 ppts |
Profitability Metrics
| Metric | 2023A | 2024A | 2025A | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|
| Gross profit margin (%) | 18.6% | 19.4% | 17.7% | 18.2% | 17.8% | 17.9% |
| Operating margin (%) | 5.5% | 5.2% | 3.1% | 4.8% | 5.0% | 5.7% |
| EBITDA margin (%) | 13.7% | 15.3% | 15.3% | 16.8% | 17.8% | 18.8% |
| Return on equity (ROE) (%) | 24.0% | 24.8% | 15.1% | 13.7% | 14.8% | 15.6% |
Key Risks and Analyst Disclosures
- Key Risks: Lower sales volume or margins than expected, sector de-rating.
- Analyst Certification: The analyst certifies that the views expressed reflect personal opinions and that no compensation is directly or indirectly related to the report.
- Conflict of Interest: CMBIGM may have investment banking relationships with the companies mentioned, which could affect the report's objectivity.
CMBIGM Ratings
- BUY: Stock with potential return of over 15% over the next 12 months.
- HOLD: Stock with potential return of +15% to -10% over the next 12 months.
- SELL: Stock with potential loss of over 10% over the next 12 months.
- NOT RATED: Stock not rated by CMBIGM.
- OUTPERFORM: Industry expected to outperform the relevant broad market benchmark.
- MARKET-PERFORM: Industry expected to perform in-line with the relevant broad market benchmark.
- UNDERPERFORM: Industry expected to underperform the relevant broad market benchmark.
Disclaimer
- The report is for informational purposes only and not tailored to individual investors.
- Past performance is not indicative of future results.
- CMBIGM is not liable for any loss or damage resulting from reliance on the report.
- The report may not be reproduced or distributed without prior written consent.
Contact Information
- CMB International Global Markets Limited
- Address: 45/F, Champion Tower, 3 Garden Road, Hong Kong
- Tel: (852) 3900 0888
- Fax: (852) 3900 0800
Legal and Distribution Notes
- The report is provided only to persons falling within the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 in the UK.
- In the US, the report is intended solely for "major US institutional investors" and not for any other person.
展开完整摘要
试读结束，高清完整版pdf/doc/ppt,请点下载
